Sunday, 18 October 202610:32 pm ISTIndia edition

सच, सीधे आप तक

Book ad space

Just in

India

Zydus Presents Saroglitazar Analysis from EPICS-III Trial at ACG 2026

Image: Business Medical Dialogues. Rights remain with the publisher.

New Delhi: Zydus Therapeutics Inc., a wholly owned subsidiary of Zydus Lifesciences Ltd., has presented new exploratory analyses from the pivotal EPICS-III Phase 2(b)/3 clinical trial evaluating...

Read the full report on Business Medical Dialogues

Story file

Section
India
Places
Delhi
First reported by
Business Medical Dialogues
Reporter
sheeba farhat
Published
Sunday, 18 October 2026, 9:06 am IST
Coverage
One outlet so far

How this page works. The Headline Update lists this report from Business Medical Dialogues with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.

Related stories

More India news

See all